GLP-1 Protein Calculator — Preserve Muscle During Weight Loss

GLP-1 Protein Calculator

GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) are highly effective for weight loss — but research from the STEP trials shows that up to 40% of weight lost can come from lean mass rather than fat. Adequate protein intake is the primary nutritional strategy to counteract this.

Enter your weight, activity level, and GLP-1 status to calculate your optimal daily protein target with meal distribution guidance.

The Lean Mass Problem with GLP-1 Therapy

The STEP 1 trial (semaglutide 2.4 mg/week) demonstrated mean weight loss of 14.9% over 68 weeks. However, dual-energy X-ray absorptiometry (DEXA) scans within the trial population revealed that a meaningful proportion of this loss was lean mass — a concern because lean mass drives resting metabolic rate, physical function, and long-term weight maintenance after medication discontinuation.

Higher-protein diets during calorie restriction are well established in the bariatric surgery literature as a tool for lean mass preservation. The same principle applies to GLP-1 therapy, where the mechanism (appetite suppression + gastric slowing) creates a similarly profound calorie deficit.

Limitations

This calculator uses total body weight, not lean body mass. Individuals with high body fat may have overestimated needs; those with high muscle mass may be underestimated.
Activity levels and actual calorie expenditure vary widely — the categories are generalizations.
The 30% GLP-1 adjustment is a clinical approximation based on aggregate trial data, not individualized to your specific medication dose or duration.
This tool is for educational purposes only. Consult a registered dietitian or healthcare provider for personalized nutrition guidance.

Sources and References

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
Protein Requirements During Energy Restriction: Impact of Physical Activity. Journal of the International Society of Sports Nutrition.
Maximizing Muscle Protein Synthesis: Meal Protein Dose and Distribution. American Journal of Clinical Nutrition.

Frequently Asked Questions

Why do GLP-1 medications cause muscle loss?

GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) create a significant calorie deficit by reducing appetite and slowing gastric emptying. When the body is in a sustained calorie deficit, it draws energy from both fat tissue and lean mass (muscle). Research from the STEP clinical trials found that roughly 25–40% of total weight lost on semaglutide was lean mass, not fat. This proportion is higher than ideal and can negatively affect metabolic rate, strength, and long-term weight maintenance.

Why does the calculator add a 30% increase for GLP-1 users?

Protein plays a central role in preserving lean mass during calorie restriction. Higher protein intake stimulates muscle protein synthesis (MPS), provides satiety (important when appetite is already suppressed), and supports metabolic rate. Clinical nutrition guidelines for individuals undergoing significant calorie restriction — including bariatric surgery patients — typically recommend 1.2–1.5 g/kg/day, substantially above the standard 0.8 g/kg RDA. The 30% adjustment reflects the additional needs created by the rapid, medication-driven calorie deficit.

What is muscle protein synthesis (MPS) and why does 30–40g per meal matter?

Muscle protein synthesis is the cellular process by which muscle fibers incorporate amino acids to repair and grow. Research shows that MPS is maximally stimulated by approximately 30–40g of high-quality protein per meal. Consuming less per sitting may fail to reach this threshold; consuming significantly more provides limited additional MPS benefit per meal (excess is oxidized). Distributing total daily protein across 3–5 meals of 30–40g optimizes the anabolic stimulus across the day.

Does resistance training help prevent muscle loss on GLP-1 medications?

Yes — resistance training is the most evidence-based intervention for preserving lean mass during weight loss on GLP-1 therapy. Progressive resistance training (compound movements, moderate-to-high intensity, 2–4x/week) provides a mechanical stimulus that directly signals muscle fibers to maintain and adapt rather than atrophy. A 2024 study showed that GLP-1 users who combined semaglutide with resistance training preserved significantly more lean mass than those using medication alone.

How do I use the protein target if my appetite is very suppressed?

GLP-1 medications significantly reduce appetite, making it challenging to consume adequate protein. Strategies include: prioritizing protein-first at every meal before carbohydrates or fats, using protein shakes (25–30g per serving) to supplement solid food, choosing high-protein-density foods (Greek yogurt, cottage cheese, eggs, poultry), and spreading intake across 4–5 smaller meals rather than 2–3 large ones. If you are consistently unable to reach your protein target due to nausea or satiety, consult your healthcare provider.

Does body composition (fat vs. muscle ratio) affect my protein needs?

Yes. Protein recommendations based on total body weight can overestimate needs in individuals with high body fat, since adipose tissue has minimal protein turnover. More precise methods use lean body mass (LBM) or fat-free mass for calculations. This calculator uses total body weight as a practical approximation, which is simpler and still effective for most users. If you know your body fat percentage, multiply your lean mass (kg) by 1.6–2.2 g/kg for a more precise target.